Clinical variables | OR | 95%CI | p |
---|---|---|---|
Univariate analyses | |||
Age | 1.04 | 1.01–1.07 | 0.021 |
Male gender | 0.61 | 0.23–1.65 | 0.332 |
Arthritis | 1.05 | 0.22–5.04 | 0.95 |
Skin Rash | 0.86 | 0.28–2.59 | 0.786 |
Myalgia | 5.06 | 1.12–22.97 | 0.036 |
Splenomegaly | 1.87 | 0.58–6.03 | 0.290 |
Lymph node involvement | 3.34 | 1.04–10.69 | 0.042 |
Sore throat | 1.63 | 0.58–4.62 | 0.355 |
Liver Involvement | 0.96 | 0.35–2.65 | 0.941 |
Pleuritis | 7.34 | 2.53–20.67 | < 0.001 |
Pericarditis | 2.78 | 0.98–7.92 | 0.060 |
Abdominal pain | 7.80 | 2.59–23.51 | < 0.001 |
Systemic score | 2.14 | 1.54–2.97 | < 0.001 |
Systemic score ≥ 7 | 19.16 | 4.20–87.41 | < 0.001 |
MAS | 1.39 | 0.42–4.62 | 0.592 |
Leucocytosis > 15,000/mm3 | 1.45 | 0.53–3.99 | 0.467 |
ESR | 1.01 | 0.98–1.02 | 0.819 |
CRP | 1.32 | 0.85–2.06 | 0.214 |
Ferritin | 1.48 | 0.95–2.31 | 0.083 |
Low dosage of GCs | 0.36 | 0.11–1.16 | 0.086 |
Synthetic DMARDs | 0.84 | 0.30–2.32 | 0.739 |
Biologic DMARDs | 0.88 | 0.29–2.66 | 0.831 |
Monocyclic Pattern | 0.87 | 0.31–2.48 | 0.798 |
Polycyclic disease pattern | 0.23 | 0.05–1.02 | 0.064 |
Chronic disease pattern | 0.80 | 0.25–2.59 | 0.708 |
Multivariate analyses | |||
Age | 1.04 | 1.01–1.08 | 0.044 |
Systemic score | 2.08 | 1.50–2.88 | < 0.001 |
X2 = 28.72, p < 0.001 | |||
Age | 1.05 | 1.01–1.09 | 0.011 |
Systemic score ≥ 7 | 23.31 | 4.85–42.08 | < 0.001 |
X2 = 23.06, p < 0.001 |